This is example text for design purposes...Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.
Taken from the March/April 2019 issue of The Women’s Health Activist Newsletter. Last November, the Food and Drug Administration’s (FDA) Reproductive Health Drugs Advisory Committee voted overwhelmingly in favor of brexanolone, a first-of-its-kind treatment for postpartum depression (PPD).[1] [2] We…